Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Improving adherence in ulcerative colitis patients on Mezavant
NL-OMON40052Not yet recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Salcrozine in autoimmune colitis, sponsored by Radboud University Medical Center. Primary endpoint: Compliance to 5-ASA medication at 6 months. Planned start Jul 2014; status: not yet recruiting.
02
Drugs
Salcrozine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on NL-OMON40052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40052.